ClinicalTrials.gg
Enrolling by invitationNCT05521958Updated Apr 29, 2026

Gene Expression in Lower Extremity Acute Traumatic Compartment Syndrome

An interventional study of Acute injury without compartment syndrome and Acute injury with compartment syndrome in Tibial Shaft Fracture and Tibial Plateau Fracture, sponsored by University of Utah. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-04-29.

Sponsored by University of Utah · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Non-randomized
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Tibial Plateau Fractures with a site in United States — 3 open to participants now, 5 under way, none of them phase 3. Tibial Plateau Fractures · United States.

Planned enrollment
4th of 10
80 · median 54
Started
2022
with 2 others
No phase
5 of 11
1 open now
Registered
8th of 11
by date
Lead sponsor
4 of 11
University of Utah

Among the 11 studies in Tibial Plateau Fractures with a site in United States, this one is the 4th largest by planned enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2022, is one of 5 with no phase, and was the 8th registered.

Tibial Plateau Fractures

33 studies on the registry are indexed under Tibial Plateau Fractures; 13 are open to participants now.

Browse Tibial Plateau Fractures studies →

Open to participants now

3 of the 11 studies in Tibial Plateau Fractures with a site in United States are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 5 Tibial Plateau Fractures studies recruiting now, 3 set no upper age limit and 2 stop at 75 or younger; none take children under 18; 1 takes healthy volunteers.

This study: 18 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Tibial Plateau Fractures with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to evaluate both genotypic differences and differences in local gene expression in individuals who develop acute traumatic compartment syndrome relative to control patients with at-risk lower extremity fractures who do not develop compartment syndrome.

Read the detailed description

Acute compartment syndrome is associated with infection, contractures, fracture non-union, and chronic pain syndromes. The most common cause of acute compartment syndrome is fracture. Individuals with compartment syndrome associated with a lower extremity fracture have demonstrated worse patient reported outcome scores compared to individuals who suffer lower extremity fractures alone.

The pathophysiology of compartment syndrome has been traditionally described as loss of tissue perfusion and subsequent cellular anoxia related to supra-physiologic pressure within a closed myofascial space. Both animal and clinical studies have suggested that compartment syndrome develops when the intra-compartmental pressure approaches systemic diastolic blood pressure. However, other studies have demonstrated that high absolute compartment pressures and/or narrowed delta pressures have poor sensitivity for predicting compartment syndrome, suggesting that the pathophysiology of compartment syndrome is likely more complex than the currently accepted understanding of the disease process.

Animal models suggest that fracture promotes inflammation and exacerbates microvascular dysfunction, which may act synergistically with elevated intra-compartmental pressures to create clinical compartment syndrome. It is known that fracture causes microvascular damage and inflammation in surrounding muscle tissue. Several models have demonstrated that the microvascular environment in compartment syndrome is characterized by tenuous, intermittent blood supply to the musculature, which displays asymmetric microvascular dysfunction in response to elevated compartment pressures. Similarly, recent animal research has demonstrated that elevated intra-compartmental pressure is associated with a pro-inflammatory state, which directly contributes to skeletal muscle injury and may exacerbate microvascular injury.

It is unknown whether individual genomic and/or transcriptomic variability is clinically relevant with respect to response to fracture or the development of compartment syndrome. However, there is evidence from the vascular surgery literature in both animal and human models that individual variability in gene expression meaningfully affects skeletal muscle response to acute ischemia. The investigators hypothesize that there may be an individual pre-disposition to developing clinical compartment syndrome in the setting of at-risk fractures which manifests itself in the cellular response to inflammation and low grade ischemia. The overarching goal of this study is to characterize cellular level dysfunction in human compartment syndrome and to determine whether there are unique gene expression profiles associated with the development of clinical compartment syndrome. Specific aim 1 of this study is to compare genetic and transcriptomic differences individuals with high-risk tibia fractures who do not develop compartment syndrome and individuals with high-risk tibia fractures who do develop clinical compartment syndrome. Specific aim 2 of this study is to to compare genetic differences between acute compartment syndrome patients and chronic exertional compartment syndrome patients.

03

Conditions studied

  • Tibial Shaft Fracture
  • Tibial Plateau Fracture

Keywords

  • tibial shaft or tibial plateau fracture
  • acute compartment syndrome
  • without acute compartment syndrome
  • exertional compartment syndrome
  • gene expression
  • myostatin
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient 18+ years of age. English speaking.
  • Patients with the clinical diagnosis of lower leg acute compartment syndrome secondary to tibial shaft or tibial plateau fracture.
  • Patients without clinical compartment syndrome undergoing operative intervention within 48 hours of injury for tibial shaft or tibial plateau fractures.
  • Patients with the clinical diagnosis of exertional compartment syndrome with planned surgical intervention.

Exclusion criteria

Exclusion Criteria:

  • Non-english speaking participants
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Other
    Acute tibial shaft or tibial plateau fractures without compartment syndrome

    Patients with acute lower leg fractures who do not have clinical compartment syndrome.

    Procedure: Acute injury without compartment syndrome

  • Other
    Acute tibial shaft or tibial plateau fractures with compartment syndrome.

    Patients with acute lower leg fractures with acute compartment syndrome.

    Procedure: Acute injury with compartment syndrome

  • Other
    Exertional compartment syndrome

    Patients with a diagnosis of exertional compartment syndrome who are planning to undergo surgical procedure to release the compartment fascia will be recruited to participate prior to surgical intervention.

    Procedure: Exertional compartment syndrome

Interventions

  • ProcedureAcute injury without compartment syndrome

    Acute tibial shaft or tibial plateau fractures who do not have clinical compartment syndrome. Muscle punch biopsy of the anterior compartment will be taken.

  • ProcedureAcute injury with compartment syndrome

    Acute tibial shaft or tibial plateau fractures who have clinical compartment syndrome. Muscle punch biopsy of the anterior compartment will be taken.

  • ProcedureExertional compartment syndrome

    For patients with exertional compartment syndrome, a muscle biopsy will be obtained from affected extremity.

06

What researchers measure

Primary outcomes

  1. Myostatin (% increase)

    The investigators primary marker of interest is myostatin. The investigators will determine the (%) increase in myostatin levels in muscle tissues between compartment syndrome patients versus fracture controls. (%) increase in myostatin levels in muscle tissues between compartment syndrome patients versus patients with exertional compartment syndrome will also be determined. The measurement tool is polymerase chain reaction (PCR).

    Time frame: Immediately after the muscle tissue harvest procedure.

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2022 (actual). Primary completion is estimated for Jun 2028, 72 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 15, 2022
First posted
Aug 30, 2022
StartActual
Jun 10, 2022
Primary completionEst.
Jun 2028
CompletionEst.
Jun 2028
Last update
Apr 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05521958
Lead sponsor
University of Utah
Responsible party
Justin Haller (Principle Investigator, University of Utah) — Principal investigator
First posted
Aug 30, 2022
Start date
Jun 10, 2022
Primary completion
Jun 2028 (estimated)
Completion
Jun 2028 (estimated)
Last update
Apr 29, 2026

Study contacts

Justin Haller, M.D.
principal investigator · University of Utah Orthopaedics

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion